ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen brokerages that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and one has given a strong […]
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen brokerages that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and one has given a strong […]
